World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Immunology
Australia
2026

D-Index & Metrics

Best Scientists

D-Index
188
Citations
135126
World Ranking
456
National Ranking
1

Immunology

D-Index
191
Citations
142460
World Ranking
20
National Ranking
1

Medicine

D-Index
191
Citations
142460
World Ranking
252
National Ranking
4

Research.com Recognitions

  • 2026 - Research.com Immunology in Australia Leader Award
  • 2026 - Research.com Medicine in Australia Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Immunology in Austria Leader Award
  • 2025 - Research.com Medicine in Austria Leader Award
  • 2023 - Research.com Immunology in Australia Leader Award
  • 2023 - Research.com Medicine in Australia Leader Award
  • 2022 - Research.com Immunology in Australia Leader Award
  • 2022 - Research.com Medicine in Australia Leader Award
  • 2017 - Fellow of the Australian Academy of Science
  • 1995 - Gottschalk Medal, Australian Academy of Science

Overview

Mark J. Smyth is an independent scientist and consultant based in Australia whose research primarily spans the fields of immunology and microbiology, with significant contributions to medicine. Smyth's work focuses on immunology, oncology, and molecular biology, supported by research themes in immune cell function and interaction, cancer immunotherapy and biomarkers, and CAR-T cell therapy research.

The scientist's publication record includes research in frequent coauthorship with Tobias Bald, Kyohei Nakamura, Christian Engwerda, Xian-Yang Li, and Michele W.L. Teng, each collaborating on multiple papers.

Smyth has published extensively in notable journals such as Nature Immunology, Immunity, Cancer Immunology Research, Journal of Clinical Investigation, and the Journal for ImmunoTherapy of Cancer. These venues reflect the interdisciplinary nature of Smyth's research within immunology and oncology.

  • Nature Immunology (5 publications)
  • Immunity (4 publications)
  • Cancer Immunology Research (3 publications)
  • Journal of Clinical Investigation (3 publications)
  • Journal for ImmunoTherapy of Cancer (2 publications)

Among recent scholarly contributions, Smyth is associated with papers such as:

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death, 2020, Journal for ImmunoTherapy of Cancer
  • The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies, 2020, Nature Immunology
  • Targeting CD39 in cancer, 2020, Nature Reviews Immunology
  • The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation, 2020, Nature Immunology
  • BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection, 2021, Cell

The scientist's research topics include immune cells in cancer, T-cell and B-cell immunology, immunotherapy and immune responses, and peptidase inhibition and analysis. Smyth's work intersects with areas of physiology and even aspects of electrical and electronic engineering, indicating a multidisciplinary approach.

  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Peptidase Inhibition and Analysis
  • Immune cells in cancer
  • T-cell and B-cell Immunology

Smyth's career includes recognition in the form of awards, notably the Gottschalk Medal from the Australian Academy of Science in 1995 and being elected a Fellow of the Australian Academy of Science in 2017.

Best Publications

  • Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

    Robert D. Schreiber;Lloyd J. Old;Mark J. Smyth;Mark J. Smyth

  • Natural Innate and Adaptive Immunity to Cancer

    Matthew D. Vesely;Michael H. Kershaw;Michael H. Kershaw;Michael H. Kershaw;Robert D. Schreiber;Mark J. Smyth;Mark J. Smyth

  • Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

    François Ghiringhelli;Lionel Apetoh;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Laetitia Aymeric;Laetitia Aymeric;Laetitia Aymeric

  • Immune surveillance of tumors.

    Jeremy B. Swann;Mark J. Smyth

  • New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape

    Deepak Mittal;Matthew M Gubin;Robert D Schreiber;Mark J Smyth;Mark J Smyth

  • Adaptive immunity maintains occult cancer in an equilibrium state

    Catherine M. Koebel;William Vermi;William Vermi;Jeremy B. Swann;Jeremy B. Swann;Nadeen Zerafa

  • Cancer immunoediting and resistance to T cell-based immunotherapy

    Jake S. O’Donnell;Jake S. O’Donnell;Michele W. L. Teng;Michele W. L. Teng;Mark J. Smyth;Mark J. Smyth

  • Functional significance of the perforin/granzyme cell death pathway

    Joseph A. Trapani;Mark J. Smyth

  • NKT cells: what's in a name?

    Dale I Godfrey;H Robson MacDonald;Mitchell Kronenberg;Mark J Smyth

  • Classifying Cancers Based on T-cell Infiltration and PD-L1

    Michele W.L. Teng;Michele W.L. Teng;Shin Foong Ngiow;Antoni Ribas;Mark J. Smyth;Mark J. Smyth

  • Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

    Hirokazu Matsushita;Hirokazu Matsushita;Matthew D. Vesely;Daniel C. Koboldt;Charles G. Rickert

  • Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

    S. Loi;S. Loi;S. Michiels;S. Michiels;R. Salgado;N. Sirtaine

  • Type I interferons in anticancer immunity

    Laurence Zitvogel;Lorenzo Galluzzi;Oliver Kepp;Mark J. Smyth

  • Translational biology of osteosarcoma

    Maya Kansara;Michele W. Teng;Mark J. Smyth;David M. Thomas

  • NKT cells: facts, functions and fallacies

    Dale I. Godfrey;Kirsten J.L. Hammond;Lynn D. Poulton;Mark J. Smyth

  • Targeting natural killer cells in cancer immunotherapy

    Camille Guillerey;Camille Guillerey;Nicholas D Huntington;Nicholas D Huntington;Mark J Smyth;Mark J Smyth

  • Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    Antonella Sistigu;Takahiro Yamazaki;Erika Vacchelli;Kariman Chaba

  • Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity

    Mark J. Smyth;Gavin P. Dunn;Robert D. Schreiber

  • Differential tumor surveillance by natural killer (NK) and NKT cells

    Mark J. Smyth;Kevin Y. T. Thia;Shayna E.A. Street;Erika Cretney

  • A fresh look at tumor immunosurveillance and immunotherapy

    Mark J. Smyth;Dale I. Godfrey;Joseph A. Trapani

Frequent Co-Authors

Michele W. L. Teng
Michele W. L. Teng QIMR Berghofer Medical Research Institute
Joseph A. Trapani
Joseph A. Trapani Peter MacCallum Cancer Centre
Phillip K. Darcy
Phillip K. Darcy Peter MacCallum Cancer Centre
Michael H. Kershaw
Michael H. Kershaw Peter MacCallum Cancer Centre
Dale I. Godfrey
Dale I. Godfrey University of Melbourne
Geoffrey R. Hill
Geoffrey R. Hill Fred Hutchinson Cancer Research Center
Kazuyoshi Takeda
Kazuyoshi Takeda Juntendo University
Hideo Yagita
Hideo Yagita Juntendo University
Shin Foong Ngiow
Shin Foong Ngiow University of Pennsylvania
Yoshihiro Hayakawa
Yoshihiro Hayakawa Aichi Institute of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge in Immunology, pursuing related online degrees can open doors to various healthcare careers. Accelerated nursing programs are a popular choice, with many students seeking absn programs with high acceptance rates to quickly transition into nursing roles.

If you're looking to enter nursing with more flexible entry requirements, exploring lpn programs with easiest admission requirements can be a strategic step. Licensed Practical Nurses play vital roles in patient care, often collaborating closely with immunology specialists.

Advancing further, many immunology professionals consider becoming Nurse Practitioners. To find programs that match your needs, reviewing the list of the easiest np program options can help streamline entry into more specialized practice areas.

For those focused on mental health and immunological effects, exploring top pmhnp programs with excellent clinical placement rates can provide hands-on experience in psychiatric-mental health nursing, further enhancing your professional qualifications.

Best Scientists Citing Mark J. Smyth

Trending Scientists

Recently Published Articles